The deubiquitinase OTUD4 suppresses TAK1 kinase–dependent NF-κB signaling and inflammation
Journal of Biological Chemistry · 2025
DOI: 10.1016/j.jbc.2025.110784 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Zhaohui Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha, Hu…. Hauptthemen laut MEDLINE: MAP Kinase Kinase Kinases, NF-kappa B, Signal Transduction, Inflammation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Education Department of Hunan Province, National Natural Science Foundation of China, Hunan Provincial Natural Science Foundation.
Abstract (Originalsprache)
Chronic inflammation contributes to the development of many cancers, including non-small cell lung cancer, and is characterized by persistent activation of proinflammatory NF-κB signaling. The mechanisms that restrain NF-κB signaling remain incompletely defined. Here, we identify the deubiquitinase ovarian tumor family deubiquitinase 4 (OTUD4) as a suppressor of tumor necrosis factor (TNF)-induced NF-κB activation and chronic inflammation. OTUD4 interacts with core components of the transforming growth factor β-activated kinase 1 (TAK1) signalosome, including TAK1, TAB1, and TAB3, and removes K63-linked polyubiquitin chains from substrates within this complex, such as TAK1 and TAB3, thereby reducing TNF-induced NF-κB signaling. A histidine-centered loop (His loop) in the catalytic domain is required for this K63 linkage specificity. The tumor-associated OTUD4 H148Y missense variant (c.442C>T, p.H148Y), located within this loop, retains TAK1 binding but abolishes intrinsic deubiquitinase activity toward both K63- and K48-linked chains and is associated with sustained NF-κB activation and increased proinflammatory cytokine expression. Collectively, these results reveal a mechanism that suppresses TNF-induced NF-κB signaling and links OTUD4 dysfunction to inflammation-driven oncogenesis, including non-small cell lung cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha, Hunan, China.
- The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha, Hunan, China; Peptide and Small Molecule Drug R&D Platform, Furong Labor…
Förderung
- Education Department of Hunan Province
- National Natural Science Foundation of China
- Hunan Provincial Natural Science Foundation
Zitieren
APA
Liu, Z., Wang, X., Wu, L., Min, L., Sheng, Y., Sun, Z., Deng, Y., Miao, L., Liu, Y., Li, J., & Zhao, Y. (2025). The deubiquitinase OTUD4 suppresses TAK1 kinase–dependent NF-κB signaling and inflammation. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110784
Vancouver
Liu Z, Wang X, Wu L, Min L, Sheng Y, Sun Z, et al. The deubiquitinase OTUD4 suppresses TAK1 kinase–dependent NF-κB signaling and inflammation. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.110784
BibTeX
@article{Liu2025,
author = {Liu, Zhaohui and Wang, Xiaolong and Wu, Lihui and Min, Li and Sheng, Ying and Sun, Zhiming and Deng, Yunfang and Miao, Lin and Liu, Yue and Li, Jiabing and Zhao, Yu},
title = {The deubiquitinase OTUD4 suppresses TAK1 kinase–dependent NF-κB signaling and inflammation},
journal = {Journal of Biological Chemistry},
year = {2025},
doi = {10.1016/j.jbc.2025.110784}
}
EUVIMED